Brief: Shen Nan Peng's Long Position In Ordinary Shares Of Brii Biosciences Falls To 4.79% - HKEX Filings
21/11/2022 09:19
Nov 21 (Reuters) - Hong Kong stock exchange filings:
* SHEN NAN PENG, FOUNDER OF SEQUOIA CAPITAL CHINA, LONG
POSITION
IN ORDINARY SHARES OF BRII BIOSCIENCES 2137.HK REDUCED TO
4.79% ON NOV 15 FROM 6.04% - HKEX FILINGS
Source text
Source text 2
Further company coverage: 2137.HK
(Reporting by Hong Kong newsroom)
((twinnie.siu@tr.com; 852-3462 7715;))
Recent news on Brii Biosciences
See all newsBrief: BRII Biosciences Discloses Launch Of BRISC, An SIRNA Therapeutics Discovery Platform
China's Brii Biosciences interim net loss narrows on lower R&D expenses
Brief: Brii Biosciences Announces Share Buy-Back Programme No More Than HK$60 Million
Brief: Brii Biosciences Says Arbitration Between Brii And Vir Remains In Early Stages With No Resolution
Brief: Brii Biosciences Submits Demand For Arbitration Against VIR